Get started
Author

Mohammad Shafi Kuchay

Observed names: Kuchay, Mohammad Shafi, M Shafi Kuchay, M. Kuchay, M. S. Kuchay, M. Shafi Kuchay, MOHAMMAD S. KUCHAY, MS Kuchay, Mohammad Kuchay, Mohammad S. Kuchay, Mohammad Shai Kuchay, MohammadShafi Kuchay, Muhammad Kuchay
Observed institutions: Medanta The Medicity, University of Liverpool, Sher-i-Kashmir Institute of Medical Sciences, Ghent University, Liverpool Heart and Chest Hospital, Fortis Memorial Research Institute, Medanta The Medicity, Liverpool John Moores University, Aalborg University
ORCID: 0000-0003-3933-6137
Observed ORCID: 0000-0003-3933-6137
OpenAlex ID: A5027338879
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
2018 · Mohammad Shafi Kuchay, Sonal Krishan, et al. · Diabetes Care · 691
Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
2020 · Mohammad S. Kuchay, Sonal Krishan, et al. · Diabetologia · 258
PDF
New onset diabetes, type 1 diabetes and COVID-19
2020 · Sirisha Kusuma Boddu, Geeta Aurangabadkar, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 195
Pathophysiological mechanisms underlying MAFLD
2020 · Mohammad Shafi Kuchay, Narendra Singh Choudhary, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 188
Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature
2020 · Pavan Kumar Reddy, Mohammad Shafi Kuchay, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 127
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
2021 · Mohammad Shafi Kuchay, José Ignacio Martínez-Montoro, et al. · Biomedicines · 105
PDF
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
2025 · Mohammad Shafi Kuchay, Narendra Singh Choudhary, et al. · American Journal of Physiology-Cell Physiology · 103
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
2022 · Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay · Pharmacological Research · 94
Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk
2022 · Mohammad Shafi Kuchay, José Ignacio Martínez-Montoro, et al. · Ageing Research Reviews · 86
Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review
2017 · Mohammad Shafi Kuchay, Khalid J. Farooqui, et al. · Archives of Endocrinology and Metabolism · 79
PDF
Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study
2020 · Amerta Ghosh, Ranjit Mohan Anjana, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 69
Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: A 1-year, open-label randomized study
2015 · BashirAhmad Laway, MohammadShafi Kuchay, et al. · Indian Journal of Endocrinology and Metabolism · 52
Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19
2020 · Mohammad Shafi Kuchay, Pavan Kumar Reddy, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 49
Successful Management Of Tumor‐Induced Osteomalacia with Radiofrequency Ablation: A Case Series
2019 · Sunil Kumar Mishra, Mohammad Shafi Kuchay, et al. · JBMR Plus · 42
PDF
Intrahepatic hypothyroidism in MASLD: Role of liver-specific thyromimetics including resmetirom
2024 · Mohammad Shafi Kuchay, Scott Isaacs, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 39
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024 · Huai Zhang, Giovanni Targher, et al. · Hepatology International · 37
From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years
2020 · Mohammad Shafi Kuchay, Anoop Misra · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 30
Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes
2025 · Anoop Misra, Ashish Kumar, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 27
Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms
2024 · Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay · Journal of Obesity & Metabolic Syndrome · 26
Effectiveness of diabetes education including insulin injection technique and dose adjustment through telemedicine in hospitalized patients with COVID-19
2021 · Mitali Mishra, Tarannum Bano, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 26
Levosulpiride and serum prolactin levels
2017 · MohammadShafi Kuchay, Ambrish Mithal · Indian Journal of Endocrinology and Metabolism · 25
Hypercalcemia of advanced chronic liver disease: a forgotten clinical entity!
2016 · MS Kuchay · Clinical cases in mineral and bone metabolism · 23
PDF
Research on Non-alcoholic Fatty Liver Disease From Indian Subcontinent: A Bibliometric Analysis of Publications During 2001–2022
2023 · Raju Vaishya, Brij M. Gupta, et al. · Journal of Clinical and Experimental Hepatology · 21
PDF
Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
2020 · Mohammad Shafi Kuchay, Khalid Jamal Farooqui, et al. · Advances in experimental medicine and biology · 21
Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis
2025 · Shaghayegh Khanmohammadi, Parisa Fallahtafti, et al. · Lipids in Health and Disease · 20
Works count: 92
Citation count: 2,901
H-index: 23
I10-index: 50
Year
Topic
Type